Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» February 2012
February 2012
Merck Warned by FDA on Failure to Study Januvia Treatment for Side Effects
Merck Warned by FDA on Failure to Study Januvia Treatment for Side Effects
Bloomberg
FDA
Januvia
Merck
Janumet
diabetes
Heinz Eyes Pfizer's Baby Food
Heinz Eyes Pfizer's Baby Food
Yahoo/Zacks
Pfizer
infant nutrition
Heinz
FDA adds diabetes, memory loss warnings to statins
FDA adds diabetes, memory loss warnings to statins
Reuters
statins
diabetes
FDA
Endo says Opana ER supply disruption will be temporary
Endo says Opana ER supply disruption will be temporary
InPharm
Endo
Opana ER
drug shortage
BioDelivery Sciences, FDA Reach Agreement On BNX Development Plan
BioDelivery Sciences, FDA Reach Agreement On BNX Development Plan
NASDAQ.com
FDA
BNX
BioDelivery Sciences
opiod addiction
Coronado Biosciences reports Phase 1 clinical trial results for TSO in Crohn's
Coronado Biosciences reports Phase 1 clinical trial results for TSO in Crohn's
Yahoo/Fly on the Wall
Coronado Biosciences
TSO
Crohn's Disease
Tuesday's Bio Pharma Watch List
Tuesday's Bio Pharma Watch List
Seeking Alpha
Jazz Pharmaceuticals
Questcor
Amarin
Elan
Amyris Misses on the Top and Bottom Lines
Amyris Misses on the Top and Bottom Lines
Yahoo/AP
Amyris
earnings
Isis: If Trend Holds True, Watch For A Leap After Earnings
Isis: If Trend Holds True, Watch For A Leap After Earnings
Seeking Alpha
Isis
earnings
Bayer Could Finance ‘Significant’ Acquisition, CFO Says
Bayer Could Finance ‘Significant’ Acquisition, CFO Says
Bloomberg
M&A
Bayer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »